The Opportunity: Transform Colorectal Surgery

It’s rare to stumble upon an opportunity to transform a medical area. Colospan is such a case. As it meets the most acute challenge in colorectal surgery, operates in a billion-dollar market with millions of annual surgeries, and can save up to $30,000 per patient, Colospan is geared for success.

The Opportunity: Transform Colorectal Surgery
It’s rare to stumble upon an opportunity to transform a medical area. Colospan is such a case. As it meets the most acute challenge in colorectal surgery, operates in a billion-dollar market with millions of annual surgeries, and can save up to $30,000 per patient, Colospan is geared for success.
The Opportunity: Transform Colorectal Surgery
It’s rare to stumble upon an opportunity to transform a medical area. Colospan is such a case. As it meets the most acute challenge in colorectal surgery, operates in a billion-dollar market with millions of annual surgeries, and can save up to $30,000 per patient, Colospan is geared for success.
Field Overview

Most colorectal surgery cases include the formation of a colorectal anastomosis, in which a diseased segment of the colon or rectum is removed and the two healthy segments are reconnected.
Anastomotic leakage of colon content into the abdominal cavity is a highly dangerous complication, increasing hospitalization time, re-operation rates and patient mortality. It is also is the key driver for increased costs. One study found that hospital costs for patients suffering from complications such as anastomotic leakage could reach $95,000, while the costs for complication-free patients are as low as $26,000.
In order to prevent clinical leakage, surgeons often use an external bypass, also called a diverting stoma, which allows time for anastomotic healing. After 2-6 months, the stoma is closed and removed in separate second operation. Currently, this solution is used for almost 70% of rectal procedures and high-risk colon procedures.
In addition to its devastating impact on patients’ lives, the stoma actually causes complications in 17% of the cases, and almost 20% of these temporary diversions eventually become permanent. Furthermore, the diverting stoma is not always successful in preventing leakage.
Different approaches have been attempted for supporting the anastomosis site after the surgery, however, none of these methods offer clinical proof, nor have they gained any substantial market share.

The Ostomy Pouch – Medical Risks, Personal Discomfort
Surgeons and patients could greatly benefit from an alternative for the ostomy pouch; a solution which reduces risks and costs for life-endangering complications, hospitalization and patient suffering; a solution that does not entail an additional surgical procedure for removal.
Solving the #1 Challenge in Colorectal Surgery
CG-100 – An Effective, Safe Alternative for Diverting Stoma
Colospan CG-100 is an innovative bypass device addressing the first and foremost issue in colorectal surgery, which are the complications, costs and suffering incurred by the diverting stoma pouches.

Advantages

CG-100 saves both the hospital and payer an astounding sum of around $30,000 per patient. Currently, the financial implications of the diverting stoma, generated by extended hospitalization, outpatient stoma care and the need for stoma removal surgery, are immense.

CG-100 does not require a separate operative procedure for removal, unlike the diverting stoma and other solutions. It can easily be removed at any time, surgery-free, according to the physician’s assessment of the healing process.